Skip to content

Study to evaluate the effect of continuous intake of test food on the decrease of focusing accommodation attributed to eye strain -Crossover study-

Study to evaluate the effect of continuous intake of test food on the decrease of focusing accommodation attributed to eye strain -Crossover study- - Study to evaluate the effect of continuous intake of test food on the decrease of focusing accommodation attributed to eye strain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000044917
Enrollment
30
Registered
2021-07-21
Start date
2021-07-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Take 2 tablets of test food daily after breakfast Take 2 tablets of placebo food daily after breakfast

Sponsors

IMEQRD Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age between 25 and 40 years at the time of informed consent. 2. Japanese male or female. 3. Those who have subjective symptoms of eye strain and were determined by the principal investigator to be an suitable subject for this study. 4. Those who do VDT work more than 4 hours. 5. Those whose eyesight is over 0.7 (regardless of naked or sight correction). 6. Those who do not have eye disease except ametropia (myopia, hyperopia, astigmatism). 7. Those who do not use glasses or screen having effects of blue light cut. 8. Those who are able to input electrical diary with smartphone/PC. 9. Those who received sufficient explanation about the trial, volunteered to participate after understanding the purpose, and agree to participate in the trial with written consent.

Exclusion criteria

Exclusion criteria: 1. Those who are attending a hospital or receiving treatment of medicines or Chinese medicines due to disease. 2. Those who had LASIK surgery in past. 3. Those who are receiving nutrition therapy or physical therapy under doctor's supervision. 4. Those who have a current or past medical history of severe diseases or organic eye disease. 5. Those who have entropion or trichiasis 6. Those whose measured value of astigmatometry is more than 1.25 D. 7. Those who wear eyelash extensions. 8. Those who do not have sleep enough. 9. Those who are likely to onset allergic conjunctivitis (seasonal or year-round) during this trial. 10. Those who currently and regularly use OTC medicines or quasi drugs (including eye drops), food for specified health uses, foods with functional claims, dietary supplements, or supplements. 11. Those who take yogurt or lactic acid bacteria drinks daily for health (However, except those who can quit taking them during this trial after obtaining consent). 12. Those who have current or history of drug allergies or food allergies. 13. Those who drink a lot of alcohol (60g/day alcohol conversion). 14. Those who have habit of smoking. 15. Those who are likely to change lifestyle (meal, sleep, motional activity), such as long trip, working night shift, and not able to keep certain lifestyle. 16. Those who are pregnant or lactating, or willing to be pregnant during the trial. 17. Those who had been participating in another clinical trial within one month before obtaining consent to the trial, or planning to participate during another clinical trial. 18. Those who were determined by the principal investigator to be unsuitable for this clinical test.

Design outcomes

Primary

MeasureTime frame
High frequency component (HFC) change amount

Secondary

MeasureTime frame
Amplitude of accommodation Subjective symptoms

Countries

Japan

Contacts

Public ContactHirokuni Kayama

IMEQRD Co., Ltd Planning and Sales Department

clinical-trial@imeqrd.co.jp03-6704-5968

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026